Technical Analysis for JNJ - Johnson & Johnson

Grade Last Price % Change Price Change
A 176.98 1.75% 3.04
JNJ closed up 1.75 percent on Friday, May 20, 2022, on approximately normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Flat

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
Gapped Up Strength 0.00%
NR7 Range Contraction 1.75%
Lower Bollinger Band Touch Weakness 1.75%
Fell Below 50 DMA Bearish 0.84%
50 DMA Support Bullish -1.03%
Doji - Bearish? Reversal -1.03%
Crossed Above 50 DMA Bullish -0.62%
Fell Below 50 DMA Bearish 0.07%
Stochastic Reached Oversold Weakness 0.07%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 1 ATR 2 days ago
Rose Above 10 DMA 2 days ago
60 Minute Opening Range Breakout 2 days ago
Possible NR7 2 days ago
Up 1% 2 days ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Johnson & Johnson Description

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers products used in the baby care, skin care, oral care, wound care, and women's health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON'S, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VENDÔME, LISTERINE, REMBRANDT, REACH, BAND-AID, NEOSPORIN, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products directly, as well as through surgical supply and other distributors to wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: S&P 500 Immunology Infectious Diseases Pain Pharmaceutical Products Gastrointestinal Retail Outlets Infection Pharmacology Dow Jones Component Healthcare Industry Cardiovascular Disease Skin Care Urology Hematology Pain Management Glucose Wound Insulin Diagnostic Products Neurology Energy Products Lenses Infection Prevention Blood Glucose Monitoring Contact Lens EPC Contact Lenses General Surgery Thrombosis Antipsychotic Epci Infection Prevention Products Neos Counter Pharmaceutical Products Insulin Delivery Urological Products

Is JNJ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 186.685
52 Week Low 155.72
Average Volume 7,300,063
200-Day Moving Average 169.86
50-Day Moving Average 178.34
20-Day Moving Average 178.78
10-Day Moving Average 176.86
Average True Range 3.21
RSI 47.64
ADX 17.64
+DI 18.48
-DI 21.77
Chandelier Exit (Long, 3 ATRs) 177.06
Chandelier Exit (Short, 3 ATRs) 182.32
Upper Bollinger Bands 184.93
Lower Bollinger Band 172.62
Percent B (%b) 0.35
BandWidth 6.89
MACD Line -0.77
MACD Signal Line -0.34
MACD Histogram -0.4288
Fundamentals Value
Market Cap 465.91 Billion
Num Shares 2.63 Billion
EPS 6.36
Price-to-Earnings (P/E) Ratio 27.83
Price-to-Sales 4.92
Price-to-Book 6.08
PEG Ratio 2.77
Dividend 4.04
Dividend Yield 2.28%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 181.60
Resistance 3 (R3) 181.14 179.15 180.83
Resistance 2 (R2) 179.15 177.97 179.38 180.57
Resistance 1 (R1) 178.06 177.24 178.61 178.52 180.32
Pivot Point 176.07 176.07 176.34 176.30 176.07
Support 1 (S1) 174.98 174.89 175.53 175.44 173.64
Support 2 (S2) 172.99 174.16 173.22 173.39
Support 3 (S3) 171.90 172.99 173.13
Support 4 (S4) 172.36